Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
1.30
↑ 121% above average
Average (4y)
-6.18
Historical baseline
Range
High:1.48
Low:-25.53
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.30 | +45.5% |
| 2023 | 0.90 | -39.5% |
| 2022 | 1.48 | +116.4% |
| 2021 | -9.02 | +64.7% |
| 2020 | -25.53 | - |